Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elodie Alessandri-Gradt

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Journal of Clinical Microbiology|December 25, 2015
A Pan-HIV Strategy for Complete Genome SequencingMichael G Berg, Julie Yamaguchi, Elodie Alessandri-Gradt, et al.
The Journal of Antimicrobial Chemotherapy|June 21, 2021
HIV-1 non-group M phenotypic susceptibility in vitro to bictegravir and cabotegravirCharlène Martin, Ségolène Gracias, Charlotte Charpentier, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 24, 2016
Performance Evaluation of the New HIV-1 Quantification Assay, Xpert HIV-1 Viral Load, on a Wide Panel of HIV-1 VariantsMarie Gueudin, Adeline Baron, Elodie Alessandri-Gradt, et al.
AIDS Research and Human Retroviruses|November 3, 2016
HIV-2 Surveillance with Next-Generation Sequencing Reveals Mutations in a Cytotoxic Lymphocyte-Restricted Epitope Involved in Long-Term NonprogressionJulie Yamaguchi, Catherine A Brennan, Elodie Alessandri-Gradt, et al.
Viruses|May 27, 2023
Evaluation of Analytical and Clinical Performance and Usefulness in a Real-Life Hospital Setting of Two in-House Real-Time RT-PCR Assays to Track SARS-CoV-2 Variants of ConcernAlice Moisan, Anaïs Soares, Fabienne De Oliveira, et al.
Retrovirology|January 15, 2017
Multiple HIV-1/M + HIV-1/O dual infections and new HIV-1/MO inter-group recombinant forms detected in CameroonFabienne De Oliveira, Thomas Mourez, Aurélia Vessiere, et al.
The Journal of Antimicrobial Chemotherapy|January 13, 2025
Comparison of the immunological and virological responses to cART between HIV-1/O and HIV-1/M patients followed up in FranceGuillemette Unal, Rémonie Seng, Elodie Alessandri-Gradt, et al.
Ebiomedicine|December 5, 2018
HIV rapid screening tests and self-tests: Be aware of differences in performance and cautious of vendorsThomas Mourez, Véronique Lemée, Valérie Delbos, et al.
Microbiology Spectrum|May 29, 2024
<i>In vitro</i> phenotypic susceptibility of HIV-1 non-group M to CCR5 inhibitor (maraviroc): TROPI-CO studySégolène Gracias, Ikrame El Yaalaoui, Benoît Visseaux, et al.
AIDS (London, England)|October 19, 2016
First report of transmission of a highly resistant strain of HIV-1 group OGuillemette Unal, Thomas Mourez, Marie Leoz, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Journal of Clinical Microbiology|December 25, 2015
A Pan-HIV Strategy for Complete Genome SequencingMichael G Berg, Julie Yamaguchi, Elodie Alessandri-Gradt, et al.
The Journal of Antimicrobial Chemotherapy|June 21, 2021
HIV-1 non-group M phenotypic susceptibility in vitro to bictegravir and cabotegravirCharlène Martin, Ségolène Gracias, Charlotte Charpentier, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 24, 2016
Performance Evaluation of the New HIV-1 Quantification Assay, Xpert HIV-1 Viral Load, on a Wide Panel of HIV-1 VariantsMarie Gueudin, Adeline Baron, Elodie Alessandri-Gradt, et al.
AIDS Research and Human Retroviruses|November 3, 2016
HIV-2 Surveillance with Next-Generation Sequencing Reveals Mutations in a Cytotoxic Lymphocyte-Restricted Epitope Involved in Long-Term NonprogressionJulie Yamaguchi, Catherine A Brennan, Elodie Alessandri-Gradt, et al.
Viruses|May 27, 2023
Evaluation of Analytical and Clinical Performance and Usefulness in a Real-Life Hospital Setting of Two in-House Real-Time RT-PCR Assays to Track SARS-CoV-2 Variants of ConcernAlice Moisan, Anaïs Soares, Fabienne De Oliveira, et al.
Retrovirology|January 15, 2017
Multiple HIV-1/M + HIV-1/O dual infections and new HIV-1/MO inter-group recombinant forms detected in CameroonFabienne De Oliveira, Thomas Mourez, Aurélia Vessiere, et al.
The Journal of Antimicrobial Chemotherapy|January 13, 2025
Comparison of the immunological and virological responses to cART between HIV-1/O and HIV-1/M patients followed up in FranceGuillemette Unal, Rémonie Seng, Elodie Alessandri-Gradt, et al.
Ebiomedicine|December 5, 2018
HIV rapid screening tests and self-tests: Be aware of differences in performance and cautious of vendorsThomas Mourez, Véronique Lemée, Valérie Delbos, et al.
Microbiology Spectrum|May 29, 2024
<i>In vitro</i> phenotypic susceptibility of HIV-1 non-group M to CCR5 inhibitor (maraviroc): TROPI-CO studySégolène Gracias, Ikrame El Yaalaoui, Benoît Visseaux, et al.
AIDS (London, England)|October 19, 2016
First report of transmission of a highly resistant strain of HIV-1 group OGuillemette Unal, Thomas Mourez, Marie Leoz, et al.
Pageof 4